Literature DB >> 30743248

Size-tunable MRI-visible nitroxide-based magnetic mixed micelles: preparation, stability, and theranostic application.

Kota Nagura1, Alexey Bogdanov, Natalia Chumakova, Andrey Kh Vorobiev, Satori Moronaga, Hirohiko Imai, Tetsuya Matsuda, Yohei Noda, Tomoki Maeda, Satoshi Koizumi, Koichi Sakamoto, Tsukuru Amano, Fumi Yoshino, Tatsuhisa Kato, Naoki Komatsu, Rui Tamura.   

Abstract

Metal-free magnetic mixed micelles (mean diameter: 16 nm) composed of biocompatible surfactant Tween 80 and hydrophobic pyrrolidine-N-oxyl radical were prepared by mixing them in phosphate-buffered saline. The magnetic mixed micelles were characterized by dynamic light scattering and small angle neutron scattering measurements. The stability of the micelles is found to depend on the length of alkyl side chain in the nitroxide compounds and degree of unsaturation in the hydrophobic chain in the surfactant. The size of the mixed micelle can be tuned by changing the molar ratio of Tween 80 and nitroxyl radical. In view of theranostic application of the micelle, the cytotoxicity and stability in a physiological environment was investigated; the mixed micelle exhibited no cytotoxicity, high colloidal stability and high resistance towards reduction by large excess ascorbic acid. The in vitro and in vivo magnetic resonance imaging (MRI) revealed sufficient contrast enhancement in the proton longitudinal relaxation time (T 1) weighted images. In addition, hydrophobic fluorophores and an anticancer drug are stably encapsulated in the mixed micelles and showed fluorescence (FL) upon reduction by ascorbic acid and cytotoxicity to cancer cells, respectively. For example, the paclitaxel-loaded mixed micelles efficiently suppressed cancer cell growth. Furthermore, they were found to give higher MRI contrast (higher r 1 value) in vitro than the micelles without paclitaxel. The magnetic mixed micelles presented here are promising theranostic agents in nanomedicine due to their high biocompatibility and high resistivity towards reduction as well as functioning as a drug carrier in therapy and MR or FL imaging probe in diagnosis.

Entities:  

Year:  2019        PMID: 30743248     DOI: 10.1088/1361-6528/ab0627

Source DB:  PubMed          Journal:  Nanotechnology        ISSN: 0957-4484            Impact factor:   3.874


  2 in total

1.  Enhancing the Efficacy of Metal-Free MRI Contrast Agents via Conjugating Nitroxides onto PEGylated Cross-Linked Poly(Carboxylate Ester).

Authors:  Shiwei Guo; Xiaoming Wang; Yan Dai; Xinghang Dai; Zhiqian Li; Qiang Luo; Xiuli Zheng; Zhongwei Gu; Hu Zhang; Qiyong Gong; Kui Luo
Journal:  Adv Sci (Weinh)       Date:  2020-06-03       Impact factor: 16.806

2.  A nitroxides-based macromolecular MRI contrast agent with an extraordinary longitudinal relaxivity for tumor imaging via clinical T1WI SE sequence.

Authors:  Shiwei Guo; Xiaoming Wang; Zhiqian Li; Dayi Pan; Yan Dai; Yun Ye; Xiaohe Tian; Zhongwei Gu; Qiyong Gong; Hu Zhang; Kui Luo
Journal:  J Nanobiotechnology       Date:  2021-08-14       Impact factor: 10.435

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.